Clinical Trial Update: Safety and Efficacy of Iron Reduction by Phlebotomy [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating the safety and efficacy of reducing iron levels by phlebotomy in patients with iron overload; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hereditary Hemochromatosis
• Iron Overload

Snippet

Sponsor: Andrea Kew | Conditions: Iron Overload | Phase 2 | Status: COMPLETED